Rhythm Perception Training for Stuttering
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial involves children listening to rhythms and tapping their fingers to see if there are differences between those who stutter and those who do not.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is rhythm perception training safe for humans?
How does the Rhythm discrimination treatment for stuttering differ from other treatments?
Rhythm discrimination treatment for stuttering is unique because it focuses on improving the ability to perceive and synchronize with rhythmic patterns, which can help individuals who stutter by enhancing their internal timing for speech. This approach is different from other treatments as it specifically targets the rhythm perception deficit found in people who stutter, potentially activating compensatory timing systems in the brain to improve fluency.23678
What data supports the effectiveness of the treatment Rhythm discrimination for stuttering?
Who Is on the Research Team?
Soo-Eun Chang, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for children who currently or previously had a stutter and speak English as their primary language. It's not suitable for kids with hearing loss, significant language/motor delays, head trauma with unconsciousness, major medical illnesses, neurological/psychiatric conditions under treatment, or certain facial/motor abnormalities.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants complete rhythm discrimination and finger tapping experiments annually
Follow-up
Participants are monitored for performance on rhythm tasks and brain activity
What Are the Treatments Tested in This Trial?
Interventions
- Rhythm discrimination
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator